Is thyroid cancer a terminal illness? Is the cure rate for thyroid cancer high?

Thyroid cancer is a common malignant tumor of the thyroid gland and is a very serious disease. Thyroid cancer is not a terminal disease. It has a higher cure rate than all malignant tumors, and many patients can survive for a long time. It is mainly divided into papillary thyroid cancer, follicular thyroid cancer, anaplastic thyroid cancer, and medullary thyroid cancer, and can usually be analyzed according to the type.

1. Papillary thyroid cancer: It is the most common thyroid cancer with a high cure rate. If surgical treatment is performed in time, it can usually achieve the goal of cure and may have a survival period of 10 years;

2. Follicular thyroid cancer: The prognosis is worse than that of papillary thyroid cancer. If it is discovered early and treated surgically, it may be cured, and the 5-year survival rate can reach more than 90%;

3. Anaplastic thyroid cancer: It is the most malignant thyroid cancer, with a 5-year survival rate of about 34%. The survival time is short, and because there is no specific drug, surgical treatment is the main treatment method;

4. Medullary thyroid cancer: It refers to a malignant tumor originating from the parafollicular cells of the thyroid gland, with a 10-year survival rate of about 50%. However, it is currently possible to prolong the patient's survival through surgical treatment, radionuclide therapy, endocrine therapy, and radiotherapy and chemotherapy.

If you have thyroid cancer, you should go to the hospital in time to see a doctor. After clarifying the type and stage of the tumor, choose the appropriate treatment method under the doctor's advice. Undifferentiated cancer is more malignant, has a poor treatment effect, and is prone to recurrence after treatment. The cure rate of patients with early thyroid cancer is relatively high. If lymph node metastasis or lung metastasis occurs, it may affect the patient's survival time. It is necessary to undergo radiotherapy, chemotherapy or targeted therapy under the doctor's advice.